The BMT Data Book
Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
| Author: | Reinhold Munker, Hillard M. Lazarus, Kerry Atkinson | ISBN: | 9780511738265 |
| Publisher: | Cambridge University Press | Publication: | February 26, 2009 |
| Imprint: | Cambridge University Press | Language: | English |
| Author: | Reinhold Munker, Hillard M. Lazarus, Kerry Atkinson |
| ISBN: | 9780511738265 |
| Publisher: | Cambridge University Press |
| Publication: | February 26, 2009 |
| Imprint: | Cambridge University Press |
| Language: | English |
The BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than hundred tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between stem cell versus bone marrow transplantation, autologous versus allogeneic transplantation, and conventional versus experimental treatments. This new edition summarizes research of the last 5 years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndromes, Hodgkin's and Non-Hodgkin's lymphomas. In addition, controversies and new indications - like renal cell cancer and autoimmune disorders - are discussed plus new drugs and therapies, new stem cell sources (cord blood), new transplant protocols (reduced-intensity conditioning), and a guide to electronic databases.
The BMT Data Book is an essential guide to the data, outcome studies and complex decision-making processes involved in blood and marrow stem cell transplantation. Organized according to types of diseases and procedures, it contains more than hundred tables, figures and algorithms that reflect up-to-date research and give guidance on the choices between stem cell versus bone marrow transplantation, autologous versus allogeneic transplantation, and conventional versus experimental treatments. This new edition summarizes research of the last 5 years and gives mature data for all established indications, such as acute myeloid leukemia, myelodysplastic syndromes, Hodgkin's and Non-Hodgkin's lymphomas. In addition, controversies and new indications - like renal cell cancer and autoimmune disorders - are discussed plus new drugs and therapies, new stem cell sources (cord blood), new transplant protocols (reduced-intensity conditioning), and a guide to electronic databases.
